in vivo Alzheimer Disease
Reported by cailynn johnson | February 23rd, 2024 @ 08:10 AM
As an expert in the field of neuroscience, Creative Biolabs has extensive experience in conducting safety and efficacy in vivo assessments to evaluate the pharmacological effects of drug candidates on a range of neurological disorders. We are committed to providing a variety of animal models such as Alzheimer's disease (AD) animal models, Parkinson's disease (PD) animal models, and Huntington's disease (HD) mouse models for scientific research needs. Highly predictive disease models and experience working with leading pharmaceutical companies have made Creative Biolabs the first choice for most neurological research projects. Learn more about in vivo Alzheimer Disease study.
No comments found
Please Sign in or create a free account to add a new ticket.
With your very own profile, you can contribute to projects, track your activity, watch tickets, receive and update tickets through your email and much more.
Create new ticket
Create your profile
Help contribute to this project by taking a few moments to create your personal profile. Create your profile »
cailynn johnson